WuXi Biologics (Cayman) I... (WXXWY)

PNK: WXXWY · Real-Time Price · USD

6.21

0.43 (7.53%)

At close: May 02, 2025, 3:51 PM

WuXi Biologics (Cayman) Cash Flow Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	3.4B	4.42B	3.39B	1.69B	1.01B	630.59M	252.63M	175.85M
Depreciation & Amortization	1.17B	800.67M	481.78M	303.01M	221.37M	141.53M	87.48M	93.19M
Stock-Based Compensation	1.27B	1.23B	531.92M	276.37M	203.94M	128.37M	65.08M	47.55M
Other Working Capital	-301.13M	-100.14M	-551.77M	4.23M	107.87M	-23.83M	-11.38M	n/a
Other Non-Cash Items	-279.1M	320.71M	-439M	-110.62M	-27.09M	-10.52M	261.82M	22.68M
Deferred Income Tax	n/a	701.3M	1.65B	1.82B	539.59M	430.89M	241.64M	145.73M
Change in Working Capital	-896.35M	-2B	-2.22B	-2.11B	-743.53M	-559.27M	-306.72M	-206.44M
Operating Cash Flow	4.67B	5.54B	3.43B	1.88B	1.21B	761.61M	360.28M	81.92M
Capital Expenditures	-4.23B	-5.87B	-6.51B	-6.02B	-3.21B	-1.34B	-670.6M	-428.88M
Cash Acquisitions	n/a	-131.49M	-2.54B	-155.24M	-300.82M	-1.28B	1.55B	n/a
Purchase of Investments	-15.08B	-10.77B	-59.3B	-20.35B	-4.64B	-1.06B	-2.82B	n/a
Sales Maturities Of Investments	15.64B	10.49B	58.24B	19.25B	3.91B	2.33B	1.28B	n/a
Other Investing Acitivies	261.99M	377.56M	497.48M	67.11M	-254.53M	924.51M	6.59M	7.74M
Investing Cash Flow	-3.23B	-5.91B	-9.6B	-7.22B	-4.49B	-416.07M	-2.21B	-421.14M
Debt Repayment	-818.45M	-295.02M	-52.98M	870.46M	1.91B	n/a	-902.9M	625.34M
Common Stock Repurchased	-916.92M	-2.8B	-2.52B	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.7B	507.88M	-255.75M	46.31M	-93.37M	-18.64M	-440.73M	-292.58M
Financial Cash Flow	1.96B	-2.59B	8.21B	6.57B	5.41B	3.21B	2.23B	332.76M
Net Cash Flow	3.27B	-2.61B	1.91B	890.24M	2.12B	3.58B	334.78M	10.87M
Free Cash Flow	437.2M	-326.72M	-3.08B	-4.14B	-2B	-578.98M	-310.32M	-346.96M